{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:08:54Z","timestamp":1790064534096,"version":"4.0.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>Colorectal cancer remains a major public health challenge globally and within Latin-America, where expanding mortality rates are compounded by heterogeneous access to screening programs, healthcare infrastructure. While early detection is critical to improving survival rates, conventional fecal tests and colonoscopies face significant financial, logistical, and patient-adherence barriers in resource-limited settings. Epigenetic alterations, specifically promoter hypermethylation of CpG islands, occur early during the adenoma\u2013carcinoma sequence and provide stable, highly sensitive targets for noninvasive molecular diagnostics. In this Perspective, we discuss the molecular rationale and complementary diagnostic value of combining two robustly validated epigenetic biomarkers, Syndecan-2 (SDC2), which modulates epithelial integrity and signaling, and Tissue Factor Pathway Inhibitor-2 (TFPI2), a critical serine protease inhibitor regulating extracellular matrix remodeling. Transcriptional silencing of these genes through aberrant hypermethylation reflects distinct yet commentary pathways of colorectal carcinogenesis, providing the molecular foundation for the implementation strategy proposed herein. To overcome technical barriers that currently limit the broader adoption of methylation-based screening, we present the integration of validated quantitative real-time PCR (qPCR) methylation assays with ColoGuardIA, an open-source, lightweight, Shiny-based digital application developed by our group as an implementation-oriented proof-of-concept platform. ColoGuardIA facilitates the standardized interpretation of qPCR-derived cycle threshold (Ct) values generated by previously validated methylation tests. By helping bridge the gap between molecular oncology and decentralized clinical implementation, this framework represents a scalable strategy to support the adoption of noninvasive methylation-based screening approaches and improve access to early colorectal cancer detection in Latin-America.<\/jats:p>","DOI":"10.3389\/fmolb.2026.1922606","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:37:26Z","timestamp":1790062646000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of an application for colorectal cancer prediction using SDC2 and TFPI2 methylation: an opportunity for early and noninvasive diagnosis in Latin-America"],"prefix":"10.3389","volume":"13","author":[{"given":"Fernando","family":"Hernandez-Medina","sequence":"first","affiliation":[{"name":"Laboratorio de Inmunopatolog\u00eda, Centro de Medicina Experimental, Instituto Venezolano de Investigaciones Cient\u00edficas. IVIC","place":["Caracas, Venezuela"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Cornejo","sequence":"additional","affiliation":[{"name":"Laboratorio de Biolog\u00eda de Tumores, Centro de Microbiolog\u00eda y Biolog\u00eda Celular, Instituto Venezolano de Investigaciones Cient\u00edficas. IVIC","place":["Caracas, Venezuela"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Orue","sequence":"additional","affiliation":[{"name":"Laboratorio de Biolog\u00eda de Tumores, Centro de Microbiolog\u00eda y Biolog\u00eda Celular, Instituto Venezolano de Investigaciones Cient\u00edficas. IVIC","place":["Caracas, Venezuela"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","article-title":"Global patterns and trends in colorectal cancer incidence and mortality","volume":"66","author":"Arnold","year":"2017","journal-title":"Gut"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e3189","DOI":"10.1002\/jgm.3189","article-title":"TFPI2 and NDRG4 gene promoter methylation analysis in peripheral blood mononuclear cells are novel epigenetic noninvasive biomarkers for colorectal cancer diagnosis","volume":"22","author":"Bagheri","year":"2020","journal-title":"J. Gene Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e2300439","DOI":"10.1200\/GO.23.00439","article-title":"Cancer care disparities: overcoming barriers to cancer control in Low- and middle-income countries","volume":"10","author":"Bamodu","year":"2024","journal-title":"JCO Glob. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e474","DOI":"10.1016\/S1470-2045(21)00492-7","article-title":"Cancer control in Latin America and the Caribbean: recent advances and opportunities to move forward","volume":"22","author":"Barrios","year":"2021","journal-title":"Lancet Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"B6","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3332\/ecancer.2019.920.eCollection2019","article-title":"Precision oncology in Latin America: current situation, challenges and perspectives","volume":"13","author":"Calderon-Aparicio","year":"2019","journal-title":"Ecancermedicalscience"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.3390\/ijms25063358","article-title":"Epigenetic. Alteration in colorectal cancer: potential diagnostic and prognostic implications","volume":"25","author":"Cao","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.3390\/cells9061540","article-title":"Methylation-based therapies for colorectal cancer","volume":"9","author":"Cervena","year":"2020","journal-title":"Cells"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal-cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.cgh.2019.11.042","article-title":"Racial and ethnic disparities in colorectal cancer screening pose persistent challenges to health equity","volume":"18","author":"Demb","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0140-6736(22)01438-6","article-title":"Cancer risk factors collaborators. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the global burden of disease study 2019","volume":"400","year":"2019","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13148-019-0642-0","article-title":"Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA","volume":"11","author":"Han","year":"2019","journal-title":"Clin. Epigenet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"108703","DOI":"10.1016\/j.compbiolchem.2025.108703","article-title":"Microbiome-transcriptome-histology triad enhances survival risk stratification in multiple cancers","volume":"120","author":"He","year":"2026","journal-title":"Comput. Biology Chemistry"},{"key":"B14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/bioe.13266","article-title":"Can digital health democratize health care?","volume":"38","author":"Hendl","year":"2024","journal-title":"Bioethics"},{"key":"B15","doi-asserted-by":"publisher","first-page":"7452","DOI":"10.18632\/oncotarget.13918","article-title":"Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS","volume":"8","author":"Kautto","year":"2017","journal-title":"Oncotarget"},{"key":"B16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","article-title":"Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies","volume":"16","author":"Keum","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"646","DOI":"10.22088\/IJMCM.BUMS.14.2.646","article-title":"Combined methylation analysis of SDC2 and TFPI2 in plasma: a noninvasive liquid biopsy approach for early detection of colorectal polyp","volume":"14","author":"Khabbazpour","year":"2025","journal-title":"Int. J. Mol. Cell Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"15065","DOI":"10.1038\/nrdp.2015.65","article-title":"Colorectal cancer","volume":"1","author":"Kuipers","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B19","first-page":"S0016","volume-title":"Strategies for Colorectal Cancer Screening","author":"Ladabaum","year":"2019"},{"key":"B20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12876-022-02175-3","article-title":"The methylation of SDC2 and TFPI2 defined three methylator phenotypes of colorectal cancer","volume":"22","author":"Lei","year":"2022","journal-title":"BMC Gastroenterol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"860701","DOI":"10.3389\/fonc.2022.860701","article-title":"A novel stool methylation test for the non-invasive screening of gastric and colorectal cancer","volume":"12","author":"Ma","year":"2022","journal-title":"Front. Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"622714","DOI":"10.3389\/fnut.2021.622714","article-title":"Review: the consumption of ultra-processed foods and non-communicable diseases in Latin America","volume":"8","author":"Matos","year":"2021","journal-title":"Front. Nutr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e2354256","DOI":"10.1001\/jamanetworkopen.2023.54256","article-title":"Colorectal cancer screening programs in Latin America","volume":"7","author":"Montalvan-Sanchez","year":"2024","journal-title":"JAMA"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0289675","DOI":"10.1371\/journal.pone.0289675","article-title":"Colorectal cancer disparities in Latin America: mortality trends 1990-2019 and a paradox association with human development","volume":"18","author":"Muzi","year":"2023","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0225667","DOI":"10.1371\/journal.pone.0225667","article-title":"Socioeconomic determinants of cancer screening utilisation in Latin America: a systematic review","volume":"14","author":"Nuche-Berenguer","year":"2019","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13148-017-0426-3","article-title":"Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer","volume":"9","author":"Oh","year":"2017","journal-title":"Clin. Epigenetics"},{"key":"B27","doi-asserted-by":"publisher","first-page":"114538","DOI":"10.3748\/wjg.v32.i7.114538","article-title":"Noninvasive diagnosis of colorectal adenoma: the emerging potential of blood-based biomarkers","volume":"32","author":"Qi","year":"2026","journal-title":"World J. Gastroenterol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1053\/j.gastro.2019.10.007","article-title":"International perspective on the burden of colorectal cancer and public health effects","volume":"158","author":"Rabeneck","year":"2020","journal-title":"Gastroenterology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.25122\/jml-2023-0269","article-title":"Detecting colorectal cancer using genetic and epigenetic biomarkers: screening and diagnosis","volume":"17","author":"Rezkitha","year":"2024","journal-title":"JML"},{"key":"B30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.47892\/rgp.2020.403.1123","article-title":"Colorectal cancer screening: a South American perspective","volume":"40","author":"Sanguinetti","year":"2020","journal-title":"Rev. Gastroenterol. Peru."},{"key":"B31","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.canep.2016.07.013","article-title":"Cancer patterns and trends in central and South America","volume":"44","author":"Sierra","year":"2016","journal-title":"Cancer Epidemiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1097\/JS9.0000000000000260","article-title":"Application and development of noninvasive biomarkers for colorectal cancer screening: a systematic review","volume":"109","author":"Song","year":"2023","journal-title":"Int J Surg"},{"key":"B33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e684","DOI":"10.1016\/S2589-7500(21)00238-7","article-title":"Digital technologies: a new determinant of health","volume":"3","year":"2021","journal-title":"Lancet Digit. Health"},{"key":"B35","doi-asserted-by":"publisher","first-page":"901559","DOI":"10.3389\/fphar.2022.901559","article-title":"Effects of GLP-1 receptor agonists on biological behavior of colorectal cancer cells by regulating PI3K\/AKT\/mTOR signaling pathway","volume":"13","author":"Tong","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1089\/jir.2022.0172","article-title":"Analysis of immune and inflammatory microenvironment characteristics of noncancer end-stage liver disease","volume":"43","author":"Wang","year":"2023","journal-title":"J. Interferon and Cytokine Research The Official Journal Int. Soc. Interferon Cytokine Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"965","DOI":"10.21037\/jgo-2025-319","article-title":"The diagnostic efficiency of tissue factor pathway inhibitor 2 methylation in the detection of colorectal cancer: a systematic review and meta-analysis","volume":"16","author":"Wang","year":"2025","journal-title":"J. Gastrointest. Oncol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"10516","DOI":"10.21037\/qims-24-2120","article-title":"An optimal imaging modality based on different predictive risk factors for evaluating local staging of rectal cancer preoperatively: a comparative study of MRI and endorectal ultrasound","volume":"15","author":"Yang","year":"2025","journal-title":"Quant. Imaging Med. Surg."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1128084","DOI":"10.3389\/fmed.2023.1128084","article-title":"Application of artificial intelligence in diagnosis and treatment of colorectal cancer: a novel prospect","volume":"10","author":"Yin","year":"2023","journal-title":"Front. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"706754","DOI":"10.3389\/fmolb.2021.706754","article-title":"Methylation of SDC2\/TFPI2 and its diagnostic value in colorectal tumorous lesions","volume":"8","author":"Zhang","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.2147\/CMAR.S300861","article-title":"SDC2 and TFPI2 methylation in stool samples as an integrated biomarker for early detection of colorectal cancer","volume":"13","author":"Zhang","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"bbaf580","DOI":"10.1093\/bib\/bbaf580","article-title":"Deep learning-based fusion of nuclear segmentation features for microsatellite instability and tumor mutational burden prediction in digestive tract cancers: a multicenter validation study","volume":"26","author":"Zhang","year":"2025","journal-title":"Briefings Bioinformatics"}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1922606\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:37:27Z","timestamp":1790062647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1922606\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":42,"alternative-id":["10.3389\/fmolb.2026.1922606"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2026.1922606","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"1922606"}}